Empowering LGBTQ+ Tobacco Cessation Pilot
Empowering Sexual and/or Gender Minority Tobacco Cessation: A Pilot Study
1 other identifier
interventional
20
1 country
1
Brief Summary
Sexual and/or gender minority (SGM) people have disproportionately high rates of tobacco use - the number one cause of preventable death. Reasons for this include using tobacco to cope with social minority stressors, pro-tobacco use norms in SGM social spaces and networks, and targeted tobacco industry marketing. Empowerment Theory explains how positive behavior change, like quitting smoking, can be promoted through skills development with greater participation in the public affairs of one's community. An empowerment approach may enhance tobacco cessation treatment for SGM people and other stigmatized groups because it links individual well-being with the larger social and political context. This pilot study will assess the acceptability, feasibility, and preliminary impact of empowerment-enhanced tobacco smoking cessation assistance for SGM adults. We will enroll N=20 SGM adults in Oklahoma who smoke and are willing to quit. Participants will receive standard tobacco cessation assistance through the Stephenson Cancer Center Tobacco Treatment Research Program (TTRP). Concurrently, they will also engage in 'empowerment activities', meaning SGM organizing and community-building activities, like conducting follow-up phone calls to name change clinic participants. This will be guided by an Oklahoman SGM-serving community partner. Participants will complete 8 surveys during the intervention period and 12 weeks post-quit-date, a 60-minute, in-depth exit interview, and biochemically-verified smoking status before the intervention and 12 weeks post-quit-date. This pilot study will establish collaborative relationships between the PI's team and local SGM-serving organizations, and will produce preliminary findings to support future R01-level funding to conduct a fully-powered randomized control trial of a multi-level empowerment-enhanced SGM tobacco cessation intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2022
CompletedFirst Posted
Study publicly available on registry
May 9, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 11, 2024
CompletedResults Posted
Study results publicly available
May 15, 2025
CompletedMay 15, 2025
April 1, 2025
1.1 years
April 12, 2022
March 18, 2025
April 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Retention
We will evaluate retention by calculating the proportion of participants who complete the final study visit at 12-weeks post-quit, with the goal of retaining \>80% of participants.
12-weeks post-quit
Number of Participants Endorsing That They Would Recommend This Intervention to Another LGBTQ2S+ Identified Person Who Wants to Quit Smoking
Intervention acceptability will be assessed by the participant endorsing that they would recommend this intervention to another LGBTQ2S+ identified person who wants to quit smoking.
12 weeks post-quit-date
Number of Community Partner Staff Who Perceived Their Organization's Partnership on the Intervention as Beneficial
We will qualitatively assess community partner perceptions of their organization's partnership on the intervention as beneficial by interviewing Freedom Oklahoma staff over Zoom video chat. Semi-structured, in-depth interview lasting approximately 60 minutes will discuss Freedom Oklahoma staff's perceptions of the intervention and their organization's role in it.
within 1 month of data collection completion
Number of Participants Having Had ≥ 2 Weeks With Moderate to High Adherence to the Nicotine Patch Assessed With the 4-item Medication Adherence Questionnaire (MAQ)
Treatment adherence will be assessed with the 4-item Medication Adherence Questionnaire (MAQ) and counseling session attendance tracking. The benchmark for satisfactory medication treatment adherence is having had ≥ 2 weeks with moderate to high adherence to the nicotine patch.
12 weeks post-quit-date
Number of Participants Attending at Least 4 Smoking Cessation Counseling Sessions
Counseling attendance will be assessed by tracking the proportion of counseling sessions attended by each participant by 12 weeks post-quit-date. The benchmark for satisfactory attendance is attending at least 4 counseling sessions.
12 weeks post-quit-date
Number of Participants Attending at Least 4 Volunteer Sessions
Volunteer session attendance will be assessed by tracking the proportion of sessions attended by each participant by 12 weeks post-quit-date. The benchmark for satisfactory attendance is attending at least 4 sessions.
12 weeks post-quit-date
Secondary Outcomes (3)
Number of Participants Self-reporting 7-day Point Prevalence Abstinence at Week 12
12 weeks post-quit-date
Number of Participants for Whom Self-reported Smoking Abstinence is Biochemically-verified
12 weeks post-quit-date
Number of Participants Who Reported an Increase in Adaptive Coping From Baseline to Exit
baseline and 12 weeks post-quit-date
Study Arms (1)
Empowerment activity-enhanced tobacco cessation assistance
OTHERSingle arm pilot intervention design to assess feasibility and acceptability
Interventions
Participants will receive standard Tobacco Treatment Research Program (TTRP) tobacco cessation assistance either remotely or in-person: 6 weekly counseling sessions and 12 weeks of combination NRT (nicotine patches + nicotine gum or lozenges). During the 6 weeks of counseling, participants will also engage in at least 4 'empowerment activities' (i.e., SGM social change mobilization and community-building activities48) for a total of at least 8 hours. Activities will be tailored to each participant's comfort level and skills. Examples are compiling publicly-available information about school board meetings to support community members in participating in their school districts and making follow-up phone calls with a script to Freedom OK's name change clinic participants.
Eligibility Criteria
You may qualify if:
- At least 18 years old
- Self-identify as sexual and/or gender minority
- Reside in the State of Oklahoma
- Report past 30 day use of combustible tobacco
- Willing to quit using combustible tobacco within the next 2 weeks
- English-speaking
- Willing to refrain from smoking any substance, such as cannabis, within 48 hours of expired carbon monoxide collection
- Willing to complete all intervention components and data collection activities
You may not qualify if:
- Have contraindications for nicotine replacement therapy (NRT)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Promotion Research Center
Oklahoma City, Oklahoma, 73104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Julia McQuoid
- Organization
- University of Oklahoma
Study Officials
- PRINCIPAL INVESTIGATOR
Julia McQuoid, PhD
University of Oklahoma
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2022
First Posted
May 9, 2022
Study Start
August 1, 2022
Primary Completion
September 1, 2023
Study Completion
January 11, 2024
Last Updated
May 15, 2025
Results First Posted
May 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
De-identified data will be made available to outside investigators upon request. However, it is noteworthy that data collected as part of the current proposal will be from a small sample, and will not provide sufficient information from which to draw conclusions. Rather these data will support a larger, adequately powered trial, from which data may be more complete and useful to other investigators.